Gregory G Burrows Selected Research

HLA-DR2 Antigen (HLA DR2 Antigen)

1/2012	Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
7/2009	Recombinant T cell receptor ligand treats experimental stroke.
4/2007	Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
9/2004	T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
7/2003	Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory G Burrows Research Topics

Disease

20	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2013 - 07/2003
17	Multiple Sclerosis 05/2014 - 07/2003
11	Inflammation (Inflammations) 02/2013 - 04/2004
6	Autoimmune Diseases (Autoimmune Disease) 05/2014 - 04/2005
3	Uveitis 02/2013 - 01/2010
3	Berylliosis 09/2006 - 04/2005
2	Experimental Arthritis 06/2012 - 01/2008
2	Rheumatoid Arthritis 01/2008 - 05/2004
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Leukemia 01/2018
1	Optic Neuritis (Retrobulbar Neuritis) 01/2012
1	Retinal Degeneration 01/2012
1	Infarction (Infarctions) 06/2011
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2011
1	Thrombosis (Thrombus) 11/2010
1	Disease Progression 06/2010
1	Demyelinating Diseases (Demyelinating Disease) 06/2010
1	Posterior Uveitis 01/2010
1	Stroke (Strokes) 07/2009
1	Atrophy 07/2009
1	Encephalomyelitis (Myeloencephalitis) 04/2007
1	Anterior Uveitis 06/2006
1	Thymoma (Thymic Carcinoma) 09/2004

Drug/Important Bio-Agent (IBA)

28	LigandsIBA 01/2018 - 07/2003
21	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2013 - 09/2004
18	Peptides (Polypeptides)IBA 01/2018 - 07/2003
9	AntigensIBA 01/2018 - 01/2005
7	CytokinesIBA 02/2013 - 04/2004
5	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 01/2012 - 07/2003
4	Myelin-Oligodendrocyte GlycoproteinIBA 01/2012 - 07/2003
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2005
3	ChemokinesIBA 02/2013 - 11/2007
3	Histocompatibility Antigens Class IIIBA 05/2011 - 01/2008
3	BerylliumIBA 09/2006 - 04/2005
2	Interleukin-2 (IL2)IBA 02/2013 - 04/2005
2	Interleukin-17 (Interleukin 17)IBA 02/2013 - 11/2007
2	Interleukin-6 (Interleukin 6)IBA 02/2013 - 09/2005
2	AntibodiesIBA 06/2010 - 04/2005
2	Therapeutic UsesIBA 01/2008 - 07/2003
2	myelin proteolipid protein (139-151)IBA 09/2006 - 09/2005
2	Myelin Basic ProteinIBA 06/2006 - 08/2003
1	EpitopesIBA 01/2018
1	VaccinesIBA 01/2018
1	invariant chain (Ii-Key)IBA 02/2013
1	Histones (Histone)IBA 02/2013
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 02/2013
1	Pharmaceutical PreparationsIBA 02/2013
1	Chemokine CCL5IBA 02/2013
1	ArrestinIBA 02/2013
1	InterferonsIBA 02/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 02/2013
1	Neuroprotective AgentsIBA 01/2012
1	SolutionsIBA 11/2010
1	CollagenIBA 11/2010
1	interstitial retinol-binding proteinIBA 01/2010
1	Collagen Type II (Type II Collagen)IBA 01/2008
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2007
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2007
1	Freund's AdjuvantIBA 06/2006
1	Interleukin-13IBA 09/2005
1	Genetic Markers (Genetic Marker)IBA 07/2005
1	HLA-DP Antigens (HLA-DP)IBA 04/2005
1	HLA-DR Antigens (HLA-DR)IBA 04/2005
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2005
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2004
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 09/2004
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2004
1	Pertussis ToxinIBA 05/2004
1	alpha-Crystallin B ChainIBA 02/2004
1	myelin oligodendrocyte glycoprotein (35-55)IBA 07/2003

Therapy/Procedure

11	Therapeutics 02/2013 - 04/2004
2	Immunotherapy 02/2013 - 01/2012
1	Aftercare (After-Treatment) 09/2005
1	Immunomodulation 04/2005